Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine
Martina Zappa(University of Insubria), Fabio Angeli(University of Insubria), Dina Visca(University of Insubria), Antonio Spanevello(Istituti Clinici Scientifici Maugeri), Paolo Verdecchia(Azienda Ospedaliera di Perugia)
Cited by 49
Related Papers
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring
|Journal of Hypertension|2013|1.4k
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
|European Journal of Internal Medicine|2020|1.3k
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring
|Journal of Hypertension|2014|1k
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
|Hypertension|2004|506
Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients
|Hypertension|2016|503